Lv5
1318 积分 2020-09-28 加入
大家一起进步呀
NASH field celebrates ‘hurrah moment’ with a first FDA drug approval for the liver disease
1个月前
已完结
Integrative clinical and preclinical studies identify FerroTerminator1 as a potent therapeutic drug for MASH
1个月前
已完结
Ironing out MAFLD: Therapeutic targeting of liver ferroptosis
1个月前
已完结
Vitamin B-6
1个月前
已完结
Menopause
1个月前
已完结
Epidemiology and risk factors for IBD
1个月前
已完结
ESPEN practical guideline on clinical nutrition in hospitalized patients with acute or chronic kidney disease
2个月前
已完结
Sarcopenia and Cardiovascular Diseases
2个月前
已完结
Sarcopenia
2个月前
已完结
Nuclear Magnetic Resonance–Based Metabolomics and Risk of CKD
3个月前
已完结
中药抗肝纤维化实验研究
1年前
已驳回
皖公网安备34019202002308
